Website Links
Description
BOSTON, Feb. 17, 2014 /PRNewswire/ — MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. (“CoStim”) has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient’s own immune system to better fight cancer.
Amphivena Therapeutics Inc., Wilmington, Delaware, U.S.A., is a subsidiary of Affimed and was founded in December 2012. Amphivena will partner with Affimed to discover and develop a bispecific TandAb in a hematologic indication.
Sideris Pharmaceuticals Inc. is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of transfusion-related iron overload. The company’s operations include facilities in Boston, MA, and in Gainesville, FL. For additional information please visit our website at www.siderispharmaceuticals.com.
Bristol-Myers Squibb Company (NYSE: BMY) and iPierian, Inc. announced today that Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, a class of neurodegenerative diseases associated with the pathological aggregation of Tau protein in the human brain.
Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. Astellas has approximately 17,000 employees worldwide. The organization is committed to becoming a global category leader in Urology, Immunology (including Transplantation) and Infectious diseases, Oncology, Neuroscience and Diabetes Mellitus (DM) Complications and Kidney diseases. For more information on Astellas Pharma Inc., please visit the company website at www.astellas.com/en.
Fact sheet
Company contacts
- Luke Evnin
- Partner
Products & services
Similar companies nearby
-
Graffinity Pharmaceuticals AG
Distance: 0.0 Mi111 Huntington Ave Ste 610
02199-7626 Boston -
Contracts Associates
Distance: 0.5 Mi416 Marlborough St Apt 604
02115-1507 Boston -
Third Rock Ventures, LLC
Distance: 0.6 Mi29 Newbury St
02116 Boston -
Pharma Connections Worldwide LLC
Distance: 1.2 Mi245 First St
02142 Cambridge -
Satori Pharmaceuticals Inc
Distance: 1.4 Mi75 Rogers St
02142-1118 Cambridge